FESTUCCIA, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 3.606
EU - Europa 2.067
AS - Asia 1.827
SA - Sud America 295
AF - Africa 40
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.846
Nazione #
US - Stati Uniti d'America 3.529
SG - Singapore 794
RU - Federazione Russa 526
IE - Irlanda 425
CN - Cina 386
DE - Germania 309
BR - Brasile 260
HK - Hong Kong 206
IT - Italia 202
VN - Vietnam 176
SE - Svezia 161
GB - Regno Unito 99
TR - Turchia 97
UA - Ucraina 85
FI - Finlandia 72
FR - Francia 59
CA - Canada 52
IN - India 44
BD - Bangladesh 35
BE - Belgio 33
CZ - Repubblica Ceca 25
JP - Giappone 21
ZA - Sudafrica 20
PL - Polonia 16
ES - Italia 15
NL - Olanda 14
MX - Messico 13
AR - Argentina 11
IQ - Iraq 10
PK - Pakistan 9
MA - Marocco 8
EC - Ecuador 7
LT - Lituania 7
KR - Corea 6
EU - Europa 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
UY - Uruguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
ID - Indonesia 3
JM - Giamaica 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
TW - Taiwan 3
AL - Albania 2
AT - Austria 2
BG - Bulgaria 2
BH - Bahrain 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
TN - Tunisia 2
BN - Brunei Darussalam 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PG - Papua Nuova Guinea 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 7.846
Città #
Dallas 476
Chandler 453
Singapore 451
Dublin 421
San Jose 347
Jacksonville 320
Ashburn 257
Hong Kong 199
Santa Clara 141
New York 109
Ann Arbor 103
Boardman 92
Munich 92
Council Bluffs 82
The Dalles 78
Beijing 77
Moscow 67
Izmir 60
L'aquila 58
Nanjing 57
Wilmington 57
Los Angeles 55
Bremen 53
Lawrence 53
Princeton 53
Ho Chi Minh City 51
Hanoi 41
Grafing 38
Woodbridge 38
Brussels 32
San Mateo 27
Columbus 26
Seattle 24
Shenyang 24
Orem 23
Brno 22
Helsinki 22
Nanchang 21
Lauterbourg 20
São Paulo 20
Turku 19
Montreal 18
Tokyo 18
Chennai 16
Milan 16
Falls Church 15
Frankfurt am Main 15
Houston 15
Johannesburg 15
Lappeenranta 15
Rome 15
Stockholm 15
Kunming 14
Tianjin 14
Toronto 14
Warsaw 14
L’Aquila 13
Berlin 12
Brooklyn 12
Dong Ket 12
London 11
Dearborn 10
Falkenstein 10
Mountain View 10
Phoenix 10
Amsterdam 9
Atlanta 9
Belo Horizonte 9
Changsha 9
Chicago 9
Da Nang 9
Denver 9
Des Moines 9
Haiphong 9
Manchester 9
San Francisco 9
Shanghai 9
Washington 9
Hebei 8
Jinan 8
Norwalk 8
Poplar 8
Ankara 7
Boston 7
Mumbai 7
Pune 7
Hanover 6
Hefei 6
Jiaxing 6
Mexico City 6
Napoli 6
Seoul 6
Baghdad 5
Biên Hòa 5
Charlotte 5
Curitiba 5
Dhaka 5
Francavilla al Mare 5
Rio de Janeiro 5
Verona 5
Totale 5.241
Nome #
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 203
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 202
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 195
From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis 184
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 167
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 161
PPARγ-dependent effects of conjugated linoleic acid on a human glioblastoma cell line (ADF) 160
Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds 159
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 158
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 158
Tebuconazole and Econazole Act Synergistically in Mediating Mitochondrial Stress, Energy Imbalance, and Sequential Activation of Autophagy and Apoptosis in Mouse Sertoli TM4 Cells: Possible Role of AMPK/ULK1 Axis 157
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 154
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 153
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 153
Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse 153
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 152
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 151
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 148
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 147
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 147
Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells 144
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 143
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 141
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 139
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 138
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 137
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 137
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 136
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 136
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 135
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 133
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 133
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 130
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? 130
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 129
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 125
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models 124
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 124
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 124
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 124
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 124
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 122
Editorial: Antitarget Therapies: New Frontiers in the Treatment of Cancer 120
The importance of tumor stem cells in glioblastoma resistance to therapy 119
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 116
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 115
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models 114
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models 113
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model. 109
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 108
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models 106
Editorial: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer 99
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 99
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. 96
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 95
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 94
New therapeutic approaches for the treatmemt of glioblastoma 89
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 82
A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence 74
Targeted molecular therapy in glioblastoma 54
Dental Pulp Stem Cell-Derived Organoids: Advancing the Development of 3D Structures 3
Totale 7.975
Categoria #
all - tutte 30.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 0 30
2021/2022399 22 3 68 25 12 54 16 14 35 37 25 88
2022/20231.236 73 93 18 173 105 120 0 92 502 11 30 19
2023/2024351 42 13 20 13 26 135 10 12 1 9 17 53
2024/20251.503 39 31 98 104 169 126 214 126 280 103 130 83
2025/20263.136 154 281 391 418 319 178 419 94 246 462 124 50
Totale 7.975